TuftsCSDD-Logo-Color.jpg
Contract Support and Technical Service Providers Expected to Play a Growing Role in Drug Development, According to Tufts Center for the Study of Drug Development
17 oct. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Oct 17, 2012) - Drug sponsors and their contract service providers are using more sophisticated, integrated, and coordinated relationship structures to deliver greater...
TuftsCSDD-Logo-Color.jpg
Oncology Drugs Get Faster Approvals Than Non-Oncology Drugs in U.S., but the Opposite Is True in the EU, According to Tufts Center for the Study of Drug Development
05 sept. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Sep 5, 2012) - Approval times for new oncology drugs in the United States during the last decade were shorter than approval times for non-oncology products, while the...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Teaming With Academic Medical Centers to Create New Medicines, According to Tufts Center for the Study of Drug Development
07 août 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Aug 7, 2012) - Drug developers are forging new ways to work with academic medical centers to create the next generation of breakthrough medicines, which is changing the...
TuftsCSDD-Logo-Color.jpg
U.S. Cancer Patients Get Faster Access to More Oncology Drugs Than European Patients, According to Tufts Center for the Study of Drug Development
10 juil. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jul 10, 2012) - Cancer patients in the United States get faster access to more oncology drugs to treat their disease than patients in Europe, according to a newly...
TuftsCSDD-Logo-Color.jpg
Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
09 mai 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 9, 2012) - Drug sponsors experienced a mixed regulatory burden under the FDA Amendments Act, which was also the fourth iteration of the Prescription Drug User Fee Act...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
26 avr. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Apr 26, 2012) - Drug companies looking to increase the efficiency and productivity of their R&D pipelines are turning to a host of techniques and approaches aimed at...
TuftsCSDD-Logo-Color.jpg
Drugs to Treat CNS Diseases Take 35% Longer to Develop Than Other Drugs, According to Tufts Center for the Study of Drug Development
06 mars 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Mar 6, 2012) - Drugs developed to treat central nervous system (CNS) diseases take 35% longer to complete clinical trials and receive regulatory approval compared to other...
TuftsCSDD-Logo-Color.jpg
Drug Company Executives Are Expanding Their Use of Strategic Partnerships, According to Tufts Center for the Study of Drug Development
26 janv. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 26, 2012) - Pharmaceutical and biopharmaceutical companies, under pressure to increase R&D productivity, are expanding their use of strategic partnerships to bring...
TuftsCSDD-Logo-Color.jpg
Tufts Center for the Study of Drug Development Establishes Workload and Utilization Benchmarks for Global Clinical Research Associates
17 janv. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 17, 2012) - The Tufts Center for the Study of Drug Development today announced that it has established the first global benchmark for clinical research associate (CRA)...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Taking Steps to Improve R&D Productivity, According to Tufts Center for the Study of Drug Development
05 janv. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 5, 2012) - Although drug companies are pursuing innovative approaches to increase the pace and reduce the cost of drug development, the greatest advances will come...